Description
This project will focus on the improvement and optimization of manufacturing processes in preparation for the large scale production of a monoclonal antibody required for the generation of the clinical stage antibody-drug conjugate, which t…
Amendment chain · 4 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $215,500 at start, $215,500 after amendment #4 (+$0).
- #02018-04-02$215,500
- #22019-03-29$215,500
- #32019-07-31$215,500
- #42019-12-03$215,500
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-04-02(start date) | $215,500 | — | This project will focus on the improvement and optimization of manufacturing processes in preparation for the… |
| #2 amendment | 2019-03-29 | $215,500 | +$0 | This project will focus on the improvement and optimization of manufacturing processes in preparation for the… |
| #3 amendment | 2019-07-31 | $215,500 | +$0 | This project will focus on the improvement and optimization of manufacturing processes in preparation for the… |
| #4 amendment | 2019-12-03 | $215,500 | +$0 | This project will focus on the improvement and optimization of manufacturing processes in preparation for the… |
Related records · 6
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 820342111)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2020-2021-Q1-949686 | National Research Council Canada | Conseil national de recherches Canada · Innovation Assistance Program | $315,084 | FY2021 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2018-2019-Q1-903640 · retrieved 2026-11-15.